Adenine arabinoside monophosphate coupled to lactosaminated human albumin administered for 4 weeks in patients with chronic type B hepatitis decreased viremia without producing significant side effects

Hepatology

Volumn 23, Issue 4, 1996, Pages 657-661

  Cerenzia, Maria Torrani ^a   Fiume, Luigi ^b,d   De Venon, Wilma Bernardi ^a   Lavezzo, Bruna ^a   Brunetto, Maurizia Rossana ^a   Ponzetto, Antonio ^a   Di Stefano, Giuseppina ^b   Busi, Corrado ^b   Mattioli, Alessandro ^b   Gervasi, Giovanni Battista ^c   Bonino, Ferruccio ^a   Verme, Giorgio ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Laboratori Baldacci   (Italy)

^d Dipartimento di Patologia Sperimentale   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN ALBUMIN; VIDARABINE PHOSPHATE; VIRUS DNA;

ADULT; ANTIBODY PRODUCTION; ANTIVIRAL ACTIVITY; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG INFUSION; FEMALE; HEMATOLOGICAL PARAMETERS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER FUNCTION TEST; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; URTICARIA; VIREMIA; VIRUS HEPATITIS; VIRUS INHIBITION;

ADULT; ANTIVIRAL AGENTS; CHRONIC DISEASE; DNA, VIRAL; FEMALE; HEPATITIS B; HUMANS; MALE; MIDDLE AGED; SERUM ALBUMIN; VIDARABINE PHOSPHATE; VIREMIA;

EID: 33749767889     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510230401     Document Type: Article

References (9)

1. Hoofnagle JH, Hanson RG, Minuk GY, Pappas SC, Schafer DF, Dusheiko GM, Straus SE, et al. Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis. Gastroenterology 1984;86:150-157.
2. Weller IVD, Lok ASF, Mindel A, Karayiannis P, Galpin S, Monjardino J. Sherlock S, et al. Randomized controlled trial of adenine arabinoside 5′-monophosphate (ara-AMP) in chronic hepatitis B virus infection. Gut 1985;26:745-751.
3. Ouzan D, Chevallier M, Laffranchi B, Bordon F, Chossegros P, Hantz O, Trepo C. Therapeutic efficacy of ara-AMP in symptomatic HBeAg positive CAH: a randomized placebo control study in heterosexuals. HEPATOLOGY 1986;6:1151. Abstract.
4. Garcia G, Smith CI, Weissberg JI, Eisenberg M, Bissett J, Nair PV, Mastre B, et al. Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. Ann Intern Med 1987;107:278-285.
5. Marcellin P, Ouzan D, Degos F, Brechot C, Metman EH, Degott C, Chevallier M, et al. Randomized controlled trial of adenine arabinoside 5′-monophosphate in chronic active hepatitis B: comparison of the efficacy in heterosexual and homosexual patients. HEPATOLOGY 1989;10:328-331.
6. Ouzan D, Vicaut E, Ruet C, Trepo C. Metaanalysis of randomized controlled studies of vidarabine phosphate in the treatment of HBe, HBV DNA + chronic hepatitis. J Hepatol 1991;13(suppl): 220.
7. Alexander G, Williams R. Antiviral treatment in chronic infection with hepatitis B virus. Br Med J 1986;292:915-917.
8. Balboni PG, Minia A, Grossi MP, Barbanti-Brodano G, Mattioli A, Fiume L. Activity of albumin conjugates of 5-fluorodeoxyuridine and cytosine arabinoside on poxviruses as a lysosomotropic approach to antiviral chemotherapy. Nature 1976;264:181-183.
9. Fiume L, Mattioli A, Balboni PG, Tognon M, Barbanti-Brodano G, De Vries J, Wieland TH. Enhanced inhibition of virus DNA synthesis in hepatocytes by trifluorothymidine coupled to asialofetuin. FEBS Lett 1979;103:47-51.